Farmacia
Facultad
Hospital Español
Ciudad de México, MéxicoPublicaciones en colaboración con investigadores/as de Hospital Español (8)
2021
-
Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS
Critical Care, Vol. 25, Núm. 1
2019
-
Identification of novel metabolomic biomarkers in an experimental model of septic acute kidney injury
American Journal of Physiology - Renal Physiology, Vol. 316, Núm. 1, pp. F54-F62
-
Metabolomic profile of acute respiratory distress syndrome of different etiologies
Intensive Care Medicine
2017
-
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
The Lancet Infectious Diseases, Vol. 17, Núm. 7, pp. 726-734
-
Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study
International Journal of Antimicrobial Agents, Vol. 50, Núm. 5, pp. 664-672
2016
-
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae
Mayo Clinic Proceedings, Vol. 91, Núm. 10, pp. 1362-1371
-
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae
Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 7, pp. 4159-4169
-
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 6, pp. 1672-1680